News

GenVivo Highlights GEN-1013: A Novel Delivery of an IL-12 Immunotherapy at the 2025 American Association for Cancer Research (AACR) Annual Meeting
GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV administration.Significant tumor reduction was observed in both administration routes. Both IT and IV were ...
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
Presentation will take place during the “Developmental Therapeutics - Immunotherapy” session on May 31, 2025, from 3:00 – 6:00pm CT at McCormick Place, ChicagoFORT LAUDERDALE, Fla. and WEST DES MOINES ...
Q1 2025 First Merchants Corp Earnings Call
Michele Kawiecki; Chief Financial Officer, Executive Vice President; First Merchants Corp John Martin; Executive Vice President, Chief Credit Officer; First Merchants Corp Thank you for standing by ...
Q1 2025 Matador Resources Co Earnings Call
Brian Willey; Chief Financial Officer, Executive Vice President, President - Midstream Operations; Matador Resources Co Good morning, ladies and gentlemen. Welcome to the first-quarter 2025 Matador ...
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society
Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their ...
Semperis' Guido Grillenmeier to Unpack the Microsoft Cloud Identity Crisis at RSAC 2025 Conference
Semperis, a leader in AI-powered identity security and cyber resilience, today announced that Guido Grillenmeier, Principal Technologist, EMEA, will be speaking at the RSAC 2025 Conference on The ...
Explore Scientific to Team up with RASC for Stars Across Canada Event at Ontario Observatory
RASC & Explore Scientific set to celebrate International Astronomy Day by hosting Global Star Party from historic David ...
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing ...
Taiho Oncology to Share Data in Five Presentations, Including Two Oral Presentations, at the 2025 American Society of Clinical Oncology Annual Meeting
Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors ...
PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma ...
Q1 2025 Wintrust Financial Corp Earnings Call
David Dykstra; Vice Chairman, Chief Operating Officer; Wintrust Financial Corp Richard Murphy; Vice Chairman, Chief Lending Officer; Wintrust Financial Corp Welcome to Wintrust Financial Corporation's ...